
Lipocine (LPCN) P/E Ratio
P/E Ratio as of Jun 13, 2025: -3.10
Average-3.39
Median-3.34
Minimum-3.97
Maximum-3.10
-3.10
Past Month+0.61 (16.44%)
The P/E ratio for Lipocine (LPCN) is -3.10 as of Jun 13, 2025. This represents a decrease of -102.83% compared to its 12-month average P/E ratio of 109.36. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Lipocine P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Lipocine’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Lipocine to industry peers.
Lipocine P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Lipocine’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Lipocine to industry peers.
Lipocine (LPCN) P/E Ratio Insights
See Lipocine’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Lipocine (LPCN)
Order type
Buy in
Order amount
Est. shares
0 shares
Lipocine (LPCN) P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $3.28 | -3.27 |
May 1, 2025 | $3.56 | 698.04 |
Apr 1, 2025 | $3.345 | 655.88 |
Mar 3, 2025 | $3.01 | -3.96 |
Feb 3, 2025 | $4.36 | -5.74 |
Jan 2, 2025 | $4.86 | -6.40 |
Lipocine (LPCN) End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -3.10 | -51.71% |
2024 | -6.42 | +621.35% |
2023 | -0.89 | -110.41% |
2022 | 8.55 | -108.77% |
2021 | -97.45 | +2,757.77% |
2020 | -3.41 | — |
FAQs About Lipocine (LPCN) P/E ratio
The latest P/E ratio of Lipocine (LPCN) is -3.10, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Lipocine’s last 12-month average P/E ratio is 109.36, compared to its current P/E ratio of -3.10. This reflects a decrease of -102.83%.
Lipocine’s current P/E ratio of -3.10 is lower than its last 12-month average P/E of 109.36. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Lipocine’s average P/E ratio over the last 3 years is 37.7. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Lipocine’s average P/E ratio over the last 5 years is 9.78. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.